Ren Yan, Ye Li, Huang Xia, Gao Xia, Yin Guoping, Wu Xiaofang, Huang Wenbin, Cao Linghong, Xu Ping
Department of Emergency, Zigong Fourth People's Hospital, Zigong 643000, Sichuan, China.
Institute of Medical Big Data, Zigong Medical Big Data and Artificial Intelligence Research Institute, Zigong 643000, Sichuan, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Dec;34(12):1238-1242. doi: 10.3760/cma.j.cn121430-20220317-00256.
To verify the clinical value of the good outcome following attempted resuscitation (GO-FAR) score in predicting the neurological status of patients with in-hospital cardiac arrest (IHCA) in the Chinese population.
The clinical data of patients with IHCA who were admitted to the Zigong Fourth People's Hospital from January 1 to December 31, 2020 were retrospectively analyzed. Used Glasgow-Pittsburgh cerebral performance category (CPC) score 1 point as the end point, the subjects were divided into 4 groups according to the score: ≤ 0 group, 1-8 group, 9-20 group and ≥ 21 group. Taken the group which GO-FAR score ≤ 0 as the reference group, the odds ratio (OR) of the other three groups compared with this group was calculated. The receiver operator characteristic curve (ROC curve) was performed to evaluate the predictive value of the GO-FAR score in favorable neurological outcome. A calibration curve was drawn for the Hosmer-Lemeshow test to analyze the degree of calibration of the GO-FAR score for predicting good neurological outcome.
A total of 230 IHCA patients were enrolled in the study, including 130 males, aged 74 (65, 81) years old, and 23 case (10.0%) had good neurological prognosis. There were statistically significant differences in GO-FAR-related variables, including age, a normal neurological function on admitted, acute stroke, metastatic cancer, septicemia, medical noncardiac admission, hepatic insufficiency, hypotension, renal insufficiency or dialysis, respiratory insufficiency, pneumonia, etc (all P < 0.05). Taken the GO-FAR score ≤ 0 group as the reference group, the OR values of good neurological prognosis in the GO-FAR score 1-8 group were 0.54 [95% confidence interval (95%CI) was 0.17-1.53, P = 0.250], 9-20 group were 0.17 (95%CI was 0.02-0.67, P = 0.009) and ≥ 21 group were 0.25 (95%CI was 0.05-0.85, P = 0.025). The area under the ROC curve (AUC) of the GO-FAR score for predicting favorable neurological outcome in IHCA patients was 0.653 (95%CI was 0.529-0.777, P = 0.015) and there was no significant difference in Hosmer-Lemeshow test (P = 0.311). All these suggested that there was no significant difference between the predicted value and the actual value.
GO-FAR score can be applied to predict neurological prognosis of IHCA patients in Chinese population. It can help clinicians to predict the prognosis of cardio-pulmonary resuscitation (CPR) and propose critical recommendations in treatment for these patients or their families.
验证院内心脏骤停(IHCA)患者复苏后良好结局(GO-FAR)评分对中国人群IHCA患者神经功能状态的预测临床价值。
回顾性分析2020年1月1日至12月31日自贡市第四人民医院收治的IHCA患者的临床资料。以格拉斯哥-匹兹堡脑功能分类(CPC)评分为1分为终点,根据评分将研究对象分为4组:≤0分组、1-8分组、9-20分组和≥21分组。以GO-FAR评分≤0分组为参照组,计算其他3组与该组相比的比值比(OR)。绘制受试者工作特征曲线(ROC曲线)以评估GO-FAR评分对良好神经功能结局的预测价值。绘制校准曲线用于Hosmer-Lemeshow检验,以分析GO-FAR评分预测良好神经功能结局的校准程度。
本研究共纳入230例IHCA患者,其中男性130例,年龄74(65,81)岁,23例(10.0%)神经功能预后良好。GO-FAR相关变量,包括年龄、入院时神经功能正常、急性卒中、转移性癌症、败血症、非心脏科入院、肝功能不全、低血压、肾功能不全或透析、呼吸功能不全、肺炎等,差异均有统计学意义(均P<0.05)。以GO-FAR评分≤0分组为参照组,GO-FAR评分1-8分组神经功能预后良好的OR值为0.54[95%置信区间(95%CI)为0.17-1.53,P=0.250],9-20分组为0.17(95%CI为0.02-0.67,P=0.009),≥21分组为0.25(95%CI为0.05-0.85,P=0.025)。GO-FAR评分预测IHCA患者良好神经功能结局的ROC曲线下面积(AUC)为0.653(95%CI为0.529-0.777,P=0.015),Hosmer-Lemeshow检验差异无统计学意义(P=0.311)。所有这些提示预测值与实际值之间差异无统计学意义。
GO-FAR评分可用于预测中国人群IHCA患者的神经功能预后。它有助于临床医生预测心肺复苏(CPR)的预后,并为这些患者或其家属的治疗提出关键建议。